Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
grade A 24.0 -5.03% -1.27
KRYS closed down 5.03 percent on Wednesday, January 16, 2019, on 82 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical KRYS trend table...

Date Alert Name Type % Chg
Jan 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.03%
Jan 15 Pocket Pivot Bullish Swing Setup -5.03%
Jan 15 NR7 Range Contraction -5.03%
Jan 15 Wide Bands Range Expansion -5.03%
Jan 15 Overbought Stochastic Strength -5.03%
Jan 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.27%
Jan 14 Wide Bands Range Expansion -4.27%
Jan 14 Overbought Stochastic Strength -4.27%

Older signals for KRYS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Is KRYS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 28.75
52 Week Low 8.61
Average Volume 50,539
200-Day Moving Average 16.808
50-Day Moving Average 22.8282
20-Day Moving Average 23.3415
10-Day Moving Average 25.41
Average True Range 2.3977
ADX 17.96
+DI 16.2752
-DI 21.5843
Chandelier Exit (Long, 3 ATRs ) 20.8069
Chandelier Exit (Short, 3 ATRs ) 24.0131
Upper Bollinger Band 28.048
Lower Bollinger Band 18.635
Percent B (%b) 0.57
BandWidth 40.327314
MACD Line 0.859
MACD Signal Line 0.7588
MACD Histogram 0.1002
Fundamentals Value
Market Cap 231.44 Million
Num Shares 9.64 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -38.10
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.91
Resistance 3 (R3) 27.06 26.25 26.43
Resistance 2 (R2) 26.25 25.51 26.17 26.26
Resistance 1 (R1) 25.12 25.05 24.72 24.97 26.10
Pivot Point 24.31 24.31 24.10 24.23 24.31
Support 1 (S1) 23.18 23.57 22.78 23.03 21.90
Support 2 (S2) 22.37 23.11 22.29 21.74
Support 3 (S3) 21.24 22.37 21.58
Support 4 (S4) 21.09